New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Actuate Therapeutics, Inc. (ACTU) vs Fractyl Health, Inc. (GUTS)
- Actuate Therapeutics, Inc. ACTU 0.23 +9.52%
- Fractyl Health, Inc. GUTS 0.82 −14.58%
Actuate Therapeutics, Inc. and Fractyl Health, Inc. are both Biotechnology companies. Actuate Therapeutics, Inc. and Fractyl Health, Inc. are of similar size ($12.9M and $12.7M). Across the 8 metrics below, Fractyl Health, Inc. leads on 5 and Actuate Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | ACTU | GUTS | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 46.24% | 70.18% |
| Operating margin | — | (100,570.97%) | 0.00% |
| Net margin | — | (75,732.26%) | 0.00% |
| Free cash flow margin | — | (72,350.54%) | 0.00% |
| Return on equity | (364.70%) | 905.17% | (51.58%) |
| Return on assets | (176.44%) | (82.35%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack